3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Melanoma
16
Neoplasm Metastasis
11
Ovarian Neoplasms
9
Pancreatic Neoplasms
8
Carcinoma, Non-Small-Cell Lung
8
Stomach Neoplasms
6
Skin Neoplasms
6
Leukemia, Myeloid, Acute
6
Colorectal Neoplasms
6
Carcinoma, Renal Cell
6
Triple Negative Breast Neoplasms
4
Gastrointestinal Neoplasms
4
Breast Neoplasms
4
Vulvar Neoplasms
3
Uterine Cervical Neoplasms
3
Urogenital Neoplasms
3
Rectal Neoplasms
3
Neuroblastoma
3
Myelodysplastic Syndromes
3
Multiple Myeloma
3
Leukemia
3
Colonic Neoplasms
3
Vaginal Neoplasms
2
Squamous Cell Carcinoma of Head and Neck
2
Sarcoma
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Pleural Effusion, Malignant
2
Penile Neoplasms
2
Oropharyngeal Neoplasms
2
Neoplasms
2
Interventions
pembrolizumab
5
Nivolumab
3
durvalumab
2
tremelimumab
1
relatlimab
1
fludarabine phosphate
1
fludarabine
1
avelumab
1
atezolizumab
1
Therapeutics
1
Temozolomide
1
Surgical Procedures, Operative
1
Neoadjuvant Therapy
1
Ipilimumab
1
Injections
1
Docetaxel
1
Cyclophosphamide
1
Chemotherapy, Adjuvant
1
Bevacizumab
1
ALT-803
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Microsatellite Instability
×
aldesleukin
×
1 year
×
Clear all
No trials found.